DAPT

Related by string. * * DAPT Study *

Related by context. All words. (Click for frequent words.) 73 APTIVUS r 72 NATRECOR R 72 mycophenolate mofetil 71 APTIVUS 71 decitabine 71 ritonavir boosted 71 idraparinux 71 aldosterone antagonists 71 rFVIIa 71 fulvestrant 71 tolvaptan 71 VAPRISOL 71 dual antiplatelet therapy 71 divalproex sodium 70 octreotide 70 insulin detemir 70 cilostazol 70 cinacalcet 70 platelet inhibitor 70 cangrelor 70 docetaxel Taxotere ® 70 IFN α 70 ibandronate 70 β blockers 70 clopidogrel Plavix 70 adalimumab 70 GnRH agonist 70 tipranavir 70 dosage regimens 70 Traficet EN 70 paclitaxel eluting stents 70 antiplatelet therapy 69 PREZISTA r 69 ribavirin RBV 69 teriflunomide 69 sunitinib malate 69 Pemetrexed 69 glatiramer acetate 69 canakinumab 69 ARIMIDEX 69 INTEGRILIN R 69 teriparatide 69 oral rivaroxaban 69 atazanavir ritonavir 69 ZOLINZA 69 antithrombotic therapy 69 chemoradiotherapy 69 icatibant 69 sorafenib Nexavar 69 adalimumab Humira 69 Elitek 69 antiarrhythmic drugs 69 #mg doses [002] 69 #mg dose [001] 69 peginterferon 69 direct thrombin inhibitors 69 tirofiban 69 prucalopride 69 idarubicin 69 fondaparinux 69 elective PCI 69 irbesartan 69 zoledronate 69 nadolol 69 coadministration 69 everolimus eluting stents 69 flutamide 69 Degarelix 68 visilizumab 68 CIMZIA TM 68 eptifibatide 68 anakinra 68 tocilizumab 68 rt PA 68 Trastuzumab 68 sipuleucel T 68 placebo controlled clinical 68 goserelin 68 nab paclitaxel 68 paricalcitol 68 posaconazole 68 Dasatinib 68 CIMZIA ™ 68 FASLODEX 68 IFN beta 68 abacavir lamivudine 68 antiangiogenic therapy 68 sirolimus 68 cediranib 68 abciximab 68 ropinirole 68 BYSTOLIC 68 chlorambucil 68 BENICAR HCT 68 CYPHER Stent 68 interferon ribavirin 68 alteplase 68 abatacept 68 carboplatin paclitaxel 68 fosbretabulin 68 Phase Ib clinical 68 MGd 68 lanreotide 68 GnRH agonists 68 LHRH agonist 68 fluvastatin 68 Neoadjuvant 68 azacitidine 68 docetaxel chemotherapy 68 clodronate 68 eplerenone 68 galiximab 68 trastuzumab Herceptin ® 68 bosentan 68 riociguat 68 ACTEMRA TM 68 standard chemotherapy regimen 68 pegylated liposomal doxorubicin 68 ULORIC 68 mg kg dose 68 corticosteroid dexamethasone 67 administered subcutaneously 67 GAMMAGARD 67 TACE 67 darunavir ritonavir 67 randomized multicenter trial 67 thromboprophylaxis 67 immunomodulatory therapy 67 LEXIVA r 67 Hydroxyurea 67 FOLFOX4 67 metastatic RCC 67 salmeterol fluticasone 67 antiarrhythmic drug 67 active comparator 67 alpha blocker 67 Aptivus ® 67 MYCAMINE 67 pegylated interferon alfa 67 superficial bladder cancer 67 MAGE A3 ASCI 67 relapsed MM 67 argatroban 67 HCV SPRINT 67 NATRECOR ® 67 ximelagatran 67 mRCC 67 antiplatelet agent 67 tiotropium 67 MULTAQ 67 dose atorvastatin 67 AGILECT R 67 fibrinolysis 67 relapsing multiple sclerosis 67 corticosteroid therapy 67 recurrent VTE 67 comparator arm 67 LATUDA 67 PEG IFN 67 gefitinib Iressa 67 INVEGA ® 67 TYGACIL 67 MIRCERA 67 lanthanum carbonate 67 IFN alpha 67 ATACAND 67 PROMACTA 67 bronchial thermoplasty 67 certolizumab 67 recurrent GBM 67 tamoxifen therapy 67 Carvedilol 67 efalizumab 67 antiplatelet medication 67 dose cohort 67 Xelox 67 solifenacin 67 inhibitor RG# 67 rHuPH# 67 CANCIDAS 67 bolus dose 67 FOSRENOL R 67 TYKERB 67 phase IIb clinical 67 FOLPI 67 mg QD 67 genotypic resistance 67 Peg IFN 67 lacosamide 67 ARIXTRA 67 concurrent chemoradiation 67 Tiotropium 67 recurrent glioblastoma multiforme 67 angiotensin receptor blocker ARB 67 antihypertensive therapy 66 Doxil ® 66 subcutaneously administered 66 Protelos 66 vandetanib 66 pyrazinamide 66 invasive candidiasis 66 micafungin 66 pertuzumab 66 thrombolytics 66 aldosterone antagonist 66 ara C 66 rFSH 66 nicardipine 66 bicalutamide 66 alpha 2a 66 PRADAXA 66 leflunomide 66 FIRMAGON 66 VELCADE melphalan 66 Vimpat R 66 paroxysmal AF 66 intravenous bisphosphonates 66 Fludara 66 aripiprazole Abilify 66 paroxetine Paxil 66 exemestane 66 GOUT 66 tolterodine 66 esomeprazole Nexium 66 cilengitide 66 virologic response 66 alkylating agent 66 imipenem 66 oral anticoagulation 66 double blinded randomized 66 periprocedural 66 ACZ# 66 entecavir 66 beta 1a 66 lipid lowering therapy 66 clevidipine 66 beta blocker therapy 66 mitoxantrone 66 placebo controlled studies 66 Femara letrozole 66 RE LY ® 66 drug eluting stent implantation 66 FOLFIRI 66 PEG interferon 66 virologic failure 66 Teriflunomide 66 pioglitazone 66 LY# [003] 66 Restenosis 66 epoetin alfa 66 infliximab Remicade 66 interferon alfa 2b 66 sunitinib 66 bisoprolol 66 receptor tyrosine kinase inhibitor 66 neoadjuvant 66 bendamustine 66 peg interferon 66 bisphosphonate therapy 66 MIRAPEX 66 ACTIVE W 66 daunorubicin 66 ARCOXIA 66 phase IIIb 66 degarelix 66 steroid dexamethasone 66 pimecrolimus 66 dexamethasone Decadron 66 adult chronic ITP 66 STRIDE PD 66 methotrexate monotherapy 66 postmenopausal osteoporotic women 66 nelfinavir 66 pegylated interferon alfa 2b 66 Telmisartan 66 VIRAMUNE 66 VA# [002] 66 Torisel 66 mTOR inhibitors 66 mcg dose 66 Irinotecan 66 5-FU/LV 66 platelet reactivity 66 octreotide LAR 66 dose titration 66 diabetic gastroparesis 66 trastuzumab Herceptin 66 xanthine oxidase inhibitor 66 GP IIb IIIa inhibitors 66 Bortezomib 66 placebo controlled trials 66 multicenter randomized controlled 66 Fulvestrant 66 antiplatelet drugs 66 HuMax EGFr 66 adefovir 66 colorectal liver metastases 66 fluticasone salmeterol 66 Pioglitazone 66 Randomized Evaluation 66 neurologic progression 66 pegfilgrastim 66 nucleoside analog 66 efavirenz EFV 66 Ranolazine 66 MabCampath 66 clopidogrel 66 elotuzumab 66 tarenflurbil 66 Aflibercept 66 ZD# [001] 66 haloperidol Haldol 66 viral kinetics 66 edifoligide 66 Cethromycin 66 pimozide 66 selegiline 66 Resten NG 66 tacrolimus ointment 66 biphasic insulin aspart 66 subcutaneous insulin 66 noninferiority 66 lenalidomide Revlimid R 66 Amrubicin 66 romiplostim 66 methotrexate therapy 66 erlotinib Tarceva 66 peginterferon alfa 2a 66 OADs 66 unfractionated heparin 66 risedronate 66 CIMZIA TM certolizumab pegol 66 Aortic Stenosis 66 Fondaparinux 66 ReoPro 66 fosamprenavir 66 Alfimeprase 66 TNF antagonist 66 bevacizumab Avastin 66 Noxafil 66 Vandetanib 66 plus ribavirin 66 preoperative chemotherapy 66 brivaracetam 66 stable angina 66 odanacatib 66 tapentadol ER 66 LHRH agonists 66 AZT zidovudine Retrovir 66 SCH # 66 antithrombotic 65 BRAF inhibitor 65 Fludarabine 65 Bevacizumab 65 5FU 65 #mg BID [001] 65 weekly subcutaneous injections 65 eculizumab therapy 65 IV bolus 65 TMC# r 65 ranolazine 65 cardiac toxicity 65 intravesical therapy 65 urate lowering therapy 65 tipranavir ritonavir 65 clomipramine 65 Copegus ribavirin 65 levosimendan 65 candesartan 65 PegIFN RBV 65 GW# [003] 65 Pharmacokinetic studies 65 Natalizumab 65 Exemestane 65 thromboembolic events 65 carvedilol 65 phase IIb trial 65 timolol 65 fenretinide 65 QTc prolongation 65 somatostatin analogue 65 Pharmacokinetics PK 65 tenecteplase 65 TORISEL 65 ribavirin therapy 65 Pegasys ® 65 COREG 65 anti androgen 65 rituximab Rituxan 65 Dabigatran 65 DOXIL 65 YONDELIS 65 unfractionated heparin UFH 65 BENICAR 65 trabectedin 65 aspirin clopidogrel 65 celecoxib 65 verapamil 65 Betaferon ® 65 CA4P 65 HCV RESPOND 2 65 sirolimus eluting stents 65 epoetin alpha 65 Betaferon R 65 CLARITY study 65 etanercept 65 Abatacept 65 platelet inhibition 65 Vaprisol 65 doripenem 65 Tacrolimus 65 inotropic 65 VADT 65 GPIIb IIIa 65 rilonacept 65 voriconazole 65 TPV r 65 LMWH 65 Rivaroxaban 65 EOquin TM 65 enfuvirtide 65 bevacizumab Avastin ® 65 serum calcium levels 65 AVANDIA 65 unstable angina UA 65 ziprasidone 65 LPV r 65 Moxifloxacin 65 cell lymphoma CTCL 65 eltrombopag 65 nitazoxanide 65 Peginterferon 65 vicriviroc 65 lipid lowering agents 65 RE LY 65 multicenter randomized placebo controlled 65 eprotirome 65 strontium ranelate 65 Raptiva r 65 Tipranavir 65 Perforomist Inhalation Solution 65 Methylnaltrexone 65 TMC# C# 65 temsirolimus 65 pramipexole 65 randomized Phase IIb 65 aprepitant 65 raloxifene Evista 65 dacarbazine 65 Afatinib 65 sulfasalazine 65 EXJADE 65 EURIDIS 65 abiraterone acetate 65 Cytoxan 65 anticoagulation therapy 65 EBRT 65 phase IIa clinical 65 metastatic renal cell carcinoma 65 taxane chemotherapy 65 trabedersen 65 liposomal amphotericin B 65 Nebulized 65 biliary tract cancer 65 oral ridaforolimus 65 selective modulator 65 ancrod 65 CDK inhibitor 65 neointimal hyperplasia 65 reteplase 65 INCB# [003] 65 etoposide 65 biologic therapy 65 erythropoietic 65 XELOX 65 peginterferon alfa 2b 65 HMG CoA reductase inhibitors 65 olmesartan 65 5 Fluorouracil 65 deferoxamine 65 glargine 65 DU #b 65 TAXUS Express Stent 65 LEXIVA 65 recombinant tissue plasminogen 65 budesonide formoterol 65 Tocilizumab 65 analgesic efficacy 65 primary patency 65 severe neutropenia 65 dalteparin 65 sirolimus eluting stent 65 ZYVOX 65 anastrozole 65 Myelodysplastic Syndrome MDS 65 IIIa inhibitor 65 hepatotoxicity 65 liposome injection 65 pyridostigmine 65 adriamycin 65 prospectively stratified 65 DFMO 65 zoledronic acid 65 TAXUS Stent 65 Lamotrigine 65 tegaserod 65 Teriparatide 65 oblimersen 65 carotid artery stenting 65 acute coronary syndromes ACS 65 Enzastaurin 65 KAPIDEX 65 dexmedetomidine 65 low dose cytarabine 65 zotarolimus eluting stent 65 opioid analgesia 65 Pegylated Interferon 65 multicentre randomized 65 Omacetaxine mepesuccinate 65 antithrombotics 65 pan HDAC inhibitor 65 reslizumab 65 leukemia AML 65 GnRH antagonist 65 gemcitabine Gemzar 65 bleomycin 65 intravesical 65 alfuzosin 65 dose regimens 65 TREDAPTIVE 65 liver resection 64 serum phosphate 64 azathioprine 64 bronchodilation 64 RSD# oral 64 Sorafenib 64 cabazitaxel 64 pain palliation 64 Patency 64 allopurinol 64 chronic GVHD 64 QT QTc 64 thalidomide Thalomid 64 budesonide foam 64 CCX# B 64 ACEIs 64 denileukin diftitox 64 BAL# [002] 64 PEGylated anti 64 ß blockers 64 androgen deprivation 64 CD3 monoclonal antibody 64 clinical pharmacology studies 64 MADIT II 64 cisplatin chemotherapy 64 Lenalidomide 64 losartan 64 DMARD 64 TAXUS ATLAS 64 pioglitazone HCl 64 CBLC# 64 splenectomized patients 64 chemotherapy docetaxel 64 pegylated interferon alfa 2a 64 sorafenib tablets 64 CGRP 64 pentoxifylline 64 dose dexamethasone 64 Pertuzumab 64 venlafaxine Effexor 64 mu opioid receptor antagonist 64 oxaliplatin Eloxatin 64 Mitomycin C 64 rosuvastatin #mg 64 PEGylated interferon beta 1a 64 ezetimibe simvastatin 64 Lamictal XR 64 antiepileptic drugs AEDs 64 PegIntron 64 Golimumab 64 thiazide diuretic 64 lapatinib Tykerb 64 AZILECT R 64 ascending dose 64 ADAGIO study 64 thrombolytic agents 64 alefacept 64 zalutumumab 64 AVASTIN 64 intravenous cyclophosphamide 64 PEGINTRON TM 64 pomalidomide 64 reinfarction 64 lipid lowering drugs 64 BoNTA 64 treprostinil 64 GAMMAGARD LIQUID 64 TNF inhibitor 64 bezafibrate 64 ABVD 64 BRIM2 64 somatostatin analog 64 metastatic malignant 64 Bosentan 64 ZACTIMA 64 #mg dose [003] 64 ketorolac 64 TELCYTA 64 stent implantation 64 Mylotarg 64 left ventricular dysfunction 64 HBeAg seroconversion 64 CsA 64 #:# randomization 64 mucosal healing 64 letrozole Femara 64 forodesine 64 Mg Usa 64 citalopram Celexa 64 angiogenesis inhibitor 64 tigecycline 64 multicenter placebo controlled 64 erlotinib Tarceva ® 64 pharmacokinetic interactions 64 NOXAFIL 64 gastrointestinal stromal tumors GIST 64 aripiprazole 64 BAY #-# 64 Sandostatin R 64 alfa 2a 64 anticoagulation 64 Amiodarone 64 caspofungin 64 Celecoxib 64 DEB# 64 venlafaxine 64 inhaled nitric oxide 64 sevelamer 64 Microplasmin 64 mg TID 64 amoxicillin clavulanate 64 Etanercept 64 APTIVUS R 64 SCIg 64 Valsartan 64 Xanafide 64 Interferon alfa 64 COPAXONE R 64 olanzapine 64 COPD exacerbations 64 Phase IIB 64 antimuscarinic 64 intravenously administered 64 fibrinolytic therapy 64 dabigatran etexilate 64 deferiprone 64 oral antidiabetic medication 64 Proxinium TM 64 Lubiprostone 64 tyrosine kinase inhibitor 64 sitaxsentan 64 quetiapine 64 secondary efficacy endpoints 64 cetuximab Erbitux R 64 Vidaza azacitidine 64 corifollitropin alfa 64 Subgroup analysis 64 ertapenem 64 SUTENT 64 dobutamine 64 MYDICAR 64 glatiramer 64 ARB telmisartan 64 warfarin therapy 64 ORENCIA R 64 carotid endarterectomy CEA 64 tamsulosin 64 mesalazine 64 epoetin beta 64 evaluable subjects 64 atazanavir sulfate 64 interferon IFN 64 Blinatumomab 64 Adalimumab 64 Oral Fingolimod 64 deep venous thromboses 64 mg administered orally 64 doxorubicin docetaxel 64 relapsed refractory multiple myeloma 64 palifermin 64 boosted protease inhibitor 64 VIIBRYD 64 Ozarelix 64 factor Xa 64 EFFEXOR XR 64 ISENTRESS 64 colesevelam HCl 64 potent CYP#A# inhibitors 64 infliximab 64 Phase IIIb 64 vildagliptin 64 Venlafaxine 64 TLK# 64 oral vancomycin 64 PRT# 64 androgen suppression 64 prednisone prednisolone 64 baminercept 64 intra articular injection 64 ruboxistaurin 64 intermittent claudication 64 Paraplatin ® 64 milrinone 64 peritumoral brain edema 64 isoproterenol 64 EGFR TKI 64 bolus injection 64 fibrinolytic 64 CYPHER R Sirolimus eluting 64 metastatic malignant melanoma 64 doxorubicin cyclophosphamide 64 Cyclosporine 64 refractory CLL 64 Neulasta ® 64 topotecan 64 SEROQUEL R 64 MIRAPEX ER 64 Insulin PH# 64 systemic corticosteroids 64 uric acid lowering 64 iloprost 64 TNF α 64 morphometric vertebral fractures 64 postoperative mortality 64 antimicrobial prophylaxis 64 sitagliptin 64 ALA PDT 64 diabetic neuropathic pain 64 CYT# potent vascular disrupting 64 PegIFN 64 hepatic metastases 64 serum phosphorous 64 VICTRELIS 64 Darunavir 64 chemoradiation therapy 64 oral corticosteroids 64 CLARITY TIMI 64 #mg/day [002] 64 thienopyridines 64 immunosuppressive agents 64 paclitaxel cisplatin 64 liposomal formulation 64 Ticagrelor 64 prospective randomized controlled 64 Phase Ib II 64 esomeprazole 64 Hypotension 64 imatinib therapy 64 CMV disease 64 RLAI 64 BARI 2D 64 DMARD therapy 64 thromboembolism 64 raltegravir 64 BARACLUDE ® 64 Pradefovir 64 Combination therapy 64 nilotinib 64 Sandostatin LAR 64 ALGRX 64 HBeAg positive patients 64 Advagraf 64 candesartan cilexetil 64 SNT MC# 64 randomized controlled clinical 64 PREZISTA ritonavir 64 pharmacodynamics PD 64 percutaneous intervention 64 dexrazoxane 64 Bicalutamide 64 Ecallantide 64 biologic DMARD 64 prostate cancer CRPC 64 Epirubicin 64 IV NSCLC 64 doxazosin 64 LHRH antagonists 64 APRISO 64 postoperative chemotherapy 64 nonrandomized 64 mapatumumab 64 corrected QT interval 64 interferon beta 1b 64 apremilast 64 #beta estradiol 64 iodixanol 64 BEACOPP 64 Abciximab 64 Bivalirudin 64 basiliximab 64 oral diclofenac 64 MEVACOR 64 #mg QD [001] 64 BCIRG 64 rivaroxaban 64 IRESSA 64 fluorouracil 63 transfemoral 63 FAMPYRA 63 severe exacerbations 63 intravenous dosing 63 lenalidomide dexamethasone 63 aromatase inhibitor therapy 63 perioperatively 63 PRADAXA #mg 63 Cloretazine 63 colorectal adenoma 63 antiandrogen 63 otamixaban 63 Dapagliflozin 63 sustained virological response 63 insulin lispro 63 PHPT 63 RRMS patients 63 antibiotic prophylaxis 63 desvenlafaxine succinate 63 mg dose 63 trospium 63 infusional 63 6R BH4 63 zolmitriptan 63 randomized blinded 63 muraglitazar 63 rosuvastatin 63 fallopian tube cancers 63 HBeAg positive 63 Ophena 63 Percutaneous Coronary Intervention 63 etanercept Enbrel 63 LANTUS ® 63 chemoradiation 63 briakinumab 63 antiandrogens 63 VFEND 63 tanespimycin 63 enalapril 63 darunavir 63 mesalamine granules 63 angiotensin converting enzyme inhibitor 63 indapamide 63 XIENCE V PROMUS Stent 63 receiving VICTRELIS 63 antibody MAb 63 rFIXFc 63 AA Amyloidosis 63 INTEGRILIN 63 timepoints 63 lymphadenectomy 63 Aggrenox R 63 myopathy rhabdomyolysis 63 TNF therapy 63 T2DM 63 paclitaxel Taxol 63 3TC lamivudine Epivir 63 IOP lowering 63 rindopepimut 63 fostamatinib 63 phase IIb 63 neoadjuvant treatment 63 captopril 63 Mitoxantrone 63 Granulocyte Colony Stimulating Factor 63 atorvastatin Lipitor 63 noninferior 63 Metoprolol 63 AIR CF2 63 tipranavir r 63 Acute Ischemic Stroke 63 heparins 63 Combo Stent 63 cefuroxime 63 axitinib 63 HBeAg negative 63 CHOP chemotherapy 63 dronedarone 63 periprocedural MI 63 Interferon alpha 63 glucose lowering 63 thromboembolic 63 gout flares 63 dosing cohorts 63 thrombolytic therapy 63 SYMBICORT 63 pegylated interferon alpha 63 Glypromate 63 bevacizumab 63 Mipomersen 63 EXPAREL 63 LHRH 63 Ziprasidone 63 d4T stavudine Zerit 63 glulisine 63 beta2 agonist 63 lumiliximab 63 mCi kg 63 gemcitabine cisplatin 63 flavopiridol 63 melphalan prednisone 63 docetaxel Taxotere 63 Lisofylline 63 intermittent dosing 63 Acute Coronary Syndromes ACS 63 upper gastrointestinal bleeding 63 flecainide 63 Sym# 63 RhuDex 63 RAPAFLO R 63 GVAX 63 trials RCTs 63 ADHF 63 tumor necrosis 63 treatment naive genotype 63 lispro 63 basal bolus regimen 63 Vectibix monotherapy 63 chlorthalidone 63 Candesartan 63 symptomatic VTE 63 saline placebo 63 ciclesonide 63 Oral corticosteroids 63 opioid induced bowel dysfunction 63 hydroxychloroquine 63 Tanespimycin 63 trimethoprim sulfamethoxazole 63 amphotericin B 63 APTIVUS ritonavir 63 Phase IIIb study 63 EDARBI 63 endothelin receptor antagonists 63 factor Xa inhibitor 63 NPH insulin 63 streptokinase 63 recurrent glioblastoma 63 sunitinib Sutent 63 #mg QD [002] 63 RezularTM 63 Tindamax 63 eosinophilic asthma 63 Phase 2b study 63 TACI Ig 63 dosing regimens 63 concomitant medications 63 topical diclofenac 63 certolizumab pegol 63 lopinavir ritonavir Kaletra 63 fluconazole 63 bortezomib Velcade 63 Bezielle 63 blinded randomized placebo controlled 63 cyclosporin 63 insulin sensitizing 63 Pivotal Trial 63 Intervention Effectiveness 63 carotid artery stenting CAS 63 TroVax ® 63 Adjunctive 63 XL# SAR# 63 intra arterial 63 Hepatotoxicity 63 immunomodulator 63 Dose escalation 63 aspirin heparin 63 Mg Uk 63 pramlintide metreleptin combination 63 azacytidine 63 imatinib 63 QD dosing 63 TELINTRA 63 NNRTIs 63 LT NS# 63 Free Survival PFS 63 LYSTEDA 63 anti leukemic 63 thoracoscopic lobectomy 63 ONTARGET 63 Apixaban 63 invasive aspergillosis 63 IFN alfa 63 4mg/kg 63 intravitreal injection 63 mg/m2 dose 63 dasatinib Sprycel ® 63 oral anticoagulants 63 docetaxel prednisone 63 NRTI 63 intensive lipid lowering 63 valsartan 63 galantamine

Back to home page